Research And Markets Research And Markets
0 CHECKOUT

Search for: "Cancer Therapeutics - Market Insight and R&D Pipeline Analysis"

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

Published:  April 2013
Price:  From EURUSDGBP

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline...

Published:  June 2016
Price:  From EURUSDGBP

Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development

GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers...

Published:  December 2011
Price:  From EURUSDGBP

Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline

GBI Research, the leading business intelligence provider, has released its latest research, “Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes...

Published:  July 2012
Price:  From EURUSDGBP

Epithelial Ovarian Cancer - Pipeline Review, H1 2016

Epithelial Ovarian Cancer - Pipeline Review, H1 2016 Summary ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape. The...

Published:  May 2016
Price:  From EURUSDGBP

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail Summary Leading business intelligence...

Published:  December 2012
Price:  From EURUSDGBP

Bladder Cancer - Pipeline Review, H1 2016

Bladder Cancer - Pipeline Review, H1 2016 Summary ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape. The report provides comprehensive information...

Published:  April 2016
Price:  From EURUSDGBP

Liver Cancer - Pipeline Review, H1 2016

Liver Cancer - Pipeline Review, H1 2016 Summary ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides comprehensive information...

Published:  June 2016
Price:  From EURUSDGBP

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

“Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Non Muscle...

Published:  August 2016
Price:  From EURUSDGBP

Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016

“Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Transitional Cell Cancer (Urothelial...

Published:  August 2016
Price:  From EURUSDGBP

Prostate Cancer - Pipeline Review, H1 2016

Prostate Cancer - Pipeline Review, H1 2016 Summary ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape. The report provides comprehensive...

Published:  June 2016
Price:  From EURUSDGBP

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016 Summary ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)...

Published:  May 2016
Price:  From EURUSDGBP

Head and neck Cancer - Pipeline Review, H1 2016

Head and neck Cancer - Pipeline Review, H1 2016 Summary ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape. The report provides...

Published:  April 2016
Price:  From EURUSDGBP

Pancreatic Cancer - Pipeline Review, H1 2016

Pancreatic Cancer - Pipeline Review, H1 2016 Summary ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The report provides comprehensive...

Published:  June 2016
Price:  From EURUSDGBP

Global & USA Cancer Immunotherapy Market Analysis to 2020 - Updated Edition

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint...

Published:  July 2016
Price:  From EURUSDGBP
EURUSDGBP

Global Cancer Monoclonal Antibodies Pipeline Analysis

In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer These monoclonal antibodies are designed to selectively target cancer cells and extract various responses,...

Published:  November 2013
Price:  From EURUSDGBP

Metastatic Colorectal Cancer - Pipeline Review, H1 2016

Metastatic Colorectal Cancer - Pipeline Review, H1 2016 Summary ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape....

Published:  May 2016
Price:  From EURUSDGBP

Global Orphan Cancer Drug Market & Clinical Pipeline Insight

The drug development strategies of the pharmaceutical companies is undergoing a paradigm shift from manufacturing traditional essential medicines to orphan drugs due to significant competition from...

Published:  June 2014
Price:  From EURUSDGBP

Metastatic Ovarian Cancer - Pipeline Review, H1 2016

Metastatic Ovarian Cancer - Pipeline Review, H1 2016 Summary ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Ovarian Cancer pipeline landscape. The...

Published:  April 2016
Price:  From EURUSDGBP

Oropharyngeal Cancer - Pipeline Review, H1 2016

Oropharyngeal Cancer - Pipeline Review, H1 2016 Summary ‘Oropharyngeal Cancer - Pipeline Review, H1 2016’, provides an overview of the Oropharyngeal Cancer pipeline landscape. The report provides...

Published:  May 2016
Price:  From EURUSDGBP
Loading Indicator